Stephen Knight
President & Senior Managing Partner at F-Prime Capital (formerly Fidelity Biosciences)
📍 Cambridge, Massachusetts, United States
Stephen Knight is the President and Senior Managing Partner at F-Prime Capital, specializing in biopharmaceutical and medical technology investments. He leverages his dual MD and MBA degrees from Yale University to guide and build innovative healthcare companies, drawing on a career that spans research, consulting, and venture capital.
He began his career as a researcher at the prestigious AT&T Bell Laboratories before pivoting to management consulting and later to leadership roles in the pharmaceutical and venture capital industries.
Read the full overview →Experience
36 Years
Current Role
President & Senior Managing Partner
Location
Cambridge, Massachusetts, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Stephen cares about
Biopharma Investing
He has a long track record of investing in biopharmaceuticals, holding numerous board seats at companies like Aclaris Therapeutics, Akebia, and Adaptimmune.
Medical Technology
His professional biography and investment portfolio highlight medical technology as one of his primary areas of investment focus and expertise at F-Prime Capital.
Career
Work history
10-2003
President & Senior Managing Partner
F-Prime Capital (formerly Fidelity Biosciences)
1996 - 2003
President, COO
EPIX Pharmaceuticals
1991 - 1996
Consultant
Arthur D. Little
1985 - 1985
Researcher
AT&T Bell Laboratories
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
1985 - 1990
MD
Yale School of Medicine
1988 - 1990
MBA
Yale School of Management
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.